| Titolo |
Pubblicato in |
Anno |
| Management of functional pancreatic neuroendocrine neoplasms |
CURRENT TREATMENT OPTIONS IN ONCOLOGY |
2023 |
| Utility of histopathological revision in the management of gastro-entero-pancreatic neuroendocrine neoplasia |
ENDOCRINE |
2023 |
| Role of [18F]FDG PET/CT in the management of G1 gastro-entero-pancreatic neuroendocrine tumors |
ENDOCRINE |
2022 |
| What Gastroenterologists Should Know about Carcinoid Syndrome |
GASTROENTEROLOGY INSIGHTS |
2022 |
| CT-based radiomics for prediction of therapeutic response to Everolimus in metastatic neuroendocrine tumors |
LA RADIOLOGIA MEDICA |
2022 |
| What gastroenterologists should know about carcinoid syndrome |
GASTROENTEROLOGY INSIGHTS |
2022 |
| The Antiproliferative Activity of High-Dose Somatostatin Analogs in Gastro-Entero-Pancreatic Neuroendocrine Tumors. A Systematic Review and Meta-Analysis |
JOURNAL OF CLINICAL MEDICINE |
2022 |
| Comparison of Endoscopic Techniques in the Management of Type I Gastric Neuroendocrine Neoplasia: A Systematic Review |
GASTROENTEROLOGY RESEARCH AND PRACTICE |
2021 |
| Exocrine pancreatic insufficiency and somatostatin analogs in patients with neuroendocrine neoplasia |
EXPERT OPINION ON DRUG SAFETY |
2021 |
| Efficacy of lutetium-peptide receptor radionuclide therapy in inducing prolonged tumour regression in small-bowel veuroendocrine tumours. A case of favourable response to retreatment after Initial objective response |
ONCOLOGY RESEARCH AND TREATMENT |
2021 |
| Octreotide long-acting release (LAR) in combination with other therapies for treatment of neuroendocrine neoplasia. A systematic review |
JOURNAL OF GASTROINTESTINAL ONCOLOGY |
2021 |
| Tumor heterogenity in gastro-entero-pancreatic neuroendocrine neoplasia |
ENDOCRINES |
2021 |
| Reply to Dr. Hall and coworkers |
EXPERT OPINION ON DRUG SAFETY |
2021 |
| CT texture analysis of liver metastases in PNETs versus NPNETs: correlation with histopathological findings |
EUROPEAN JOURNAL OF RADIOLOGY |
2020 |
| Occurrence of exocrine pancreatic insufficiency in patients with advanced neuroendocrine tumors treated with somatostatin analogs |
PANCREATOLOGY |
2020 |
| [18F]FDG-PET/CT and long-term responses to everolimus in advanced neuroendocrine neoplasia |
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION |
2020 |
| [18F]FDG-PET/CT and long-term response to everolimus in advanced neuroendocrine neoplasia |
ANNALS OF ONCOLOGYANNALS OF ONCOLOGY |
2020 |
| Multidisciplinary management of neuroendocrine neoplasia: a real-world experience from a referral center |
JOURNAL OF CLINICAL MEDICINE |
2019 |
| Role of combined [68Ga]Ga-DOTA-SST analogues and [18F]FDG PET/CT in the management of GEP-NENs: a systematic review |
JOURNAL OF CLINICAL MEDICINE |
2019 |
